Magnera Earnings Call Transcripts
Fiscal Year 2026
-
Strong execution drove record earnings, with revenue of $857M and adjusted EBITDA up 9% year-over-year. Guidance for free cash flow is reaffirmed, while adjusted EBITDA is expected at the lower end of the range due to inflation. Project CORE and synergy benefits are fully realized.
-
Adjusted EBITDA was $90 million, with strong free cash flow enabling $36 million in debt repayment. Weather disruptions and inflationary pressures impacted results, but guidance for full-year EBITDA and free cash flow remains unchanged, with recovery expected in Q4.
-
Magnera, formed by the merger of Berry Global's HHS division and Glatfelter, has completed integration and is focused on innovation, operational optimization, and debt reduction. The company leads in nonwovens, targets $395 million EBITDA in 2026, and manages input costs through contract mechanisms.
-
Magnera, formed from a 2024 merger, is a global leader in specialty nonwovens with a balanced revenue mix and strong innovation focus. 2026 guidance targets EBITDA growth and debt reduction, with key growth in wipes, adult incontinence, and infrastructure. Management remains confident in long-term value creation.
-
The meeting covered director elections, auditor ratification, and executive compensation approval, with all proposals passing by majority vote. No shareholder questions were submitted, and final voting results will be filed with the SEC.
-
Q1 results met expectations with $792M in sales and $93M Adjusted EBITDA, as synergy realization and Project Core drove performance despite regional headwinds. 2026 guidance targets 9% Adjusted EBITDA growth, flat volumes, and $100M in free cash flow, with strong cash generation supporting debt reduction.
Fiscal Year 2025
-
A diversified nonwovens leader highlighted strong Q4 results, raised 2026 guidance, and detailed ongoing cost optimization and innovation efforts. Regional trends showed resilience in North America and growth in adult care and healthcare, while integration synergies and deleveraging remain key priorities.
-
Q4 and full-year results exceeded expectations with strong free cash flow and improved leverage. Fiscal 2026 guidance calls for 9% EBITDA growth, driven by synergies and Project CORE, amid cautious demand outlook and continued focus on deleveraging.
-
Third quarter sales reached $839 million with $91 million in adjusted EBITDA, supported by synergy capture and cost initiatives. Project Core is set to deliver $20 million in annual savings, while full-year EBITDA guidance is confirmed at $360–$380 million.
-
A global nonwovens leader outlined its integration progress, synergy targets, and growth strategy, emphasizing innovation, operational optimization, and resilient demand across diverse end markets. Most synergy benefits are expected in 2026–2027 as utilization rates and margins improve.
-
Q2 2025 sales reached $824 million, with adjusted EBITDA at $89 million, as strong Americas and Asia results were offset by European energy inflation and South American competition. Fiscal 2025 EBITDA guidance was revised to $360–$380 million, with free cash flow guidance reaffirmed at $75–$95 million.
-
Magnera delivered strong inaugural quarter results post-merger, with revenue up 2% to $700 million and Adjusted EBITDA up 8% to $84 million, driven by improved mix and cost initiatives. FY25 guidance targets 7% earnings growth, $75–$95 million free cash flow, and ongoing deleveraging.